Showing results (351-360 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|July 24, 2017
An Update on the Use of Immunotherapy in the Treatment of LymphomaThomas U Marron, Matko Kalac, Joshua BrodyCurrent Hematologic Malignancy Reports|May 15, 2016
Exploring Big Data in Hematological Malignancies: Challenges and OpportunitiesGustavo F Westin, Ajoy L Dias, Ronald S GoCurrent Hematologic Malignancy Reports|November 4, 2017
Methods of Detection of Measurable Residual Disease in AMLYi Zhou, Brent L WoodCurrent Hematologic Malignancy Reports|September 25, 2017
Approach to MPN Symptom AssessmentHolly Geyer, Ruben A MesaCurrent Hematologic Malignancy Reports|September 27, 2017
Risk Factors for and Management of MPN-Associated Bleeding and ThrombosisKarlyn MartinCurrent Hematologic Malignancy Reports|October 14, 2017
Familial MPN PredispositionTsewang Tashi, Sabina Swierczek, Josef T PrchalCurrent Hematologic Malignancy Reports|November 23, 2022
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple MyelomaArleigh McCurdy, Alissa VisramCurrent Hematologic Malignancy Reports|June 5, 2021
Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy TreatmentsPraveen Ramakrishnan Geethakumari, Dheepthi Perumal Ramasamy, Bhagirathbhai Dholaria, et al.Current Hematologic Malignancy Reports|June 25, 2022
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid NeoplasmsMia J Sullivan, Elizabeth L Palmer, Juliana Perez BoteroCurrent Hematologic Malignancy Reports|October 26, 2016
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European CasesBradley M Haverkos, Zenggang Pan, Alejandro A Gru, et al.Pageof 86